Medical treatment of motor and nonmotor features of Parkinson’s disease. Publication: Journal Article Zesiewicz, TA, and RA Hauser. 2007. “Medical Treatment of Motor and Nonmotor Features of Parkinson’s Disease.”. Continuum.
Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson’s disease. Publication: Journal Article Hauser, RA, L Salin, N Juhel, and VL Konyago. 2007. “Randomized Trial of the Triple Monoamine Reuptake Inhibitor NS 2330 (tesofensine) in Early Parkinson’s Disease.”. Movement Disorders.
Treatment of chorea with levetiracetam. Publication: Journal Article Zesiewicz, TA, A Pathak, KL Sullivan, M Shamayev, and RA Hauser. 2006. “Treatment of Chorea With Levetiracetam.”. Eur J Clin Pharmacol.
Topiramate-induced psychosis in patients with essential tremor: report of 2 cases. Publication: Journal Article Ziesiewicz, TA, A Tullidge, J Tidwell, KL Sullivan, and RA Hauser. 2006. “Topiramate-Induced Psychosis in Patients With Essential Tremor: Report of 2 Cases.”. Clinical Neuropharmacology.
Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology... Publication: Journal Article Connors, JJ, D Sacks, AJ Furlan, WR Selman, EJ Russell, PE Stieg, MN Hadley, RA Hauser, and . 2005. “Training, Competency, and Credentialing Standards for Diagnostic Cervicocerebral Angiography, Carotid Stenting, and Cerebrovascular Intervention: A Joint Statement from the American Academy of Neurology. ”. Neurology.
Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Publication: Journal Article Zesiewicz, TA, R Elble, ED Louis, RA Hauser, KL Sullivan, RB Dewey, and . 2005. “Quality Standards Subcommittee of the American Academy of Neurology. Practice Parameter: Therapies for Essential Tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology.”. Neurology.
Positron emission tomography after fetal transplantation in Huntington’s disease. Ann Neurol 2005; 58:331-337. Publication: Journal Article Furtado, S, V Sossi, RA Hauser, A Samii, M Schulzer, CB Murphy, TB Freeman, and AJ Stoessl. 2005. “Positron Emission Tomography After Fetal Transplantation in Huntington’s Disease. Ann Neurol 2005; 58:331-337.”. Ann Neurol.
Chorea in a patient with cerebral palsy: treatment with levetiracetam. Movement Disorders 2005;20:762-764. Publication: Journal Article Recio, MV, RA Hauser, ED Louis, H Radhashakar, KL Sullivan, and TA Zesiewicz. 2005. “Chorea in a Patient With Cerebral Palsy: Treatment With Levetiracetam. Movement Disorders 2005;20:762-764.”. Movement Disorders.
Initial management of Parkinson’s disease in a Florida community. J Applied Research 2004;4:95-98. Publication: Journal Article Zesiewicz, TA, SN Carter, KL Sullivan, JS Staffetti, PB Dunne, and RA Hauser. 2004. “Initial Management of Parkinson’s Disease in a Florida Community. J Applied Research 2004;4:95-98.”. J Applied Research.
Substantial improvement in a Meige's syndrome patient with levetiracetam treatment. Movement Disorders 2004;19:1518-1521. Publication: Journal Article Zesiewicz, TA, ED Louis, KL Sullivan, M Menkin, PB Dunne, and RA Hauser. 2004. “Substantial Improvement in a Meige’s Syndrome Patient With Levetiracetam Treatment. Movement Disorders 2004;19:1518-1521.”. Movement Disorders.